These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 732067)

  • 21. [Studies on the metabolic activities of the bladder tumors. 2. Studies on the energy metabolism of the bladder tumors (author's transl)].
    Koiso K; Kakizoe T; Murahashi I; Umeda T; Ueno A
    Nihon Hinyokika Gakkai Zasshi; 1977 Jan; 68(1):22-32. PubMed ID: 557693
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on the metabolic activities of the bladder tumors. I. Studies on the nucleic acid metabolism of the bladder tumors (author's transl)].
    Koiso K; Murahashi I; Aso Y; Takayasu H
    Nihon Hinyokika Gakkai Zasshi; 1977 Jan; 68(1):11-21. PubMed ID: 557692
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of acute promyelocytic leukemia with a high thromboplastic activity in the cell extract (author's transl)].
    Tonooka T; Takeda T; Hatabe Y; Akino N
    Rinsho Ketsueki; 1974 Jul; 15(7):812-8. PubMed ID: 4530125
    [No Abstract]   [Full Text] [Related]  

  • 24. Protease and plasminogen activator activity in human bladder carcinoma.
    Gorelik U; Lindner A; Mayer M
    Br J Urol; 1990 Aug; 66(2):170-4. PubMed ID: 2202486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Established cell line of urinary bladder carcinoma (KK-47): growth, heterotransplantation, microscopic structure and chromosome pattern (author's transl)].
    Hisazumi H; Kanokogi M; Nakajima K; Kobayashi T; Tsukahara K; Naito K; Kuroda K; Matsubara F
    Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):485-94. PubMed ID: 470258
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on a plasminogen activating system in human milk: IV. Difference in the binding to fibrin between human milk plasminogen activator (mild activator) and urokinase (author's transl)].
    Horie N
    Nihon Ketsueki Gakkai Zasshi; 1979 Oct; 42(5):38-45. PubMed ID: 396753
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasminogen tissue activator in the pathogenesis of protein-long gastroenteropathy (author's transl)].
    Kondo M; Nakanishi K; Hosokawa K; Masuda M
    Rinsho Ketsueki; 1975 Jan; 16(1):59-66. PubMed ID: 1172039
    [No Abstract]   [Full Text] [Related]  

  • 28. Thromboplastic and fibrinolytic activities in various organs of congenitally athymic nude mice.
    Naito S; Tanaka K
    Acta Pathol Jpn; 1979 May; 29(3):409-11. PubMed ID: 452902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enhanced cell killing by hyperthermia and irradiation in KK-47 cells (author's transl)].
    Nakajima K
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):363-77. PubMed ID: 7401416
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro malignant conversion of low-grade rat urinary bladder carcinoma cells by exposure to N-methyl-N-nitrosourea.
    Azuma M; Momose H; Oyasu R
    Cancer Res; 1990 Nov; 50(21):7062-7. PubMed ID: 2208174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study on fibrinolytic phenomena of injured cerebral tissues. With special reference to the changes in fibrinolytic substances in glia tissues (author's transl)].
    Tadokoro H
    Nihon Geka Hokan; 1977 May; 46(3):258-77. PubMed ID: 560828
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activity of plasminogen activators and plasmin inhibitors in the joint capsule in various articular diseases (author's transl)].
    Blasini C; Glas K; Blasini R; Haas S; Wriedt-Lübbe I; Blümel G
    Z Orthop Ihre Grenzgeb; 1981 Oct; 119(5):455-62. PubMed ID: 7198342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effects of various anti-cancer drugs on nucleic acid metabolism of human bladder cancer in vitro (author's transl)].
    Umeda T; Koiso K; Takayasu H
    Nihon Hinyokika Gakkai Zasshi; 1977 Dec; 68(12):1214-7. PubMed ID: 609177
    [No Abstract]   [Full Text] [Related]  

  • 34. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of thrombin on functional activity of macrophages and lymphocytes].
    Malezhik LP; Al'fonsov VV; Budazhapova DTs
    Gematol Transfuziol; 1983 Sep; 28(9):22-7. PubMed ID: 6685079
    [No Abstract]   [Full Text] [Related]  

  • 36. [Observation on urinary fibrinolytic activity in various renal disease (author's transl)].
    Shibata M; Yamamoto A; Kishi T; Shimizu K; Kobayashi K; Sakai H; Ohtaka M
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):349-57. PubMed ID: 6458716
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active and pro-plasminogen activator on the surface of human bladder cancer cells derived from a high grade invasive tumour.
    Grant AJ; Russell PJ; Raghavan D
    Biochem Biophys Res Commun; 1990 Oct; 172(2):870-6. PubMed ID: 2173583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro plasminogen activator activity in human brain tumors.
    Tucker WS; Kirsch WM; Martinez-Hernandez A; Fink LM
    Cancer Res; 1978 Feb; 38(2):297-302. PubMed ID: 620402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cell kinetics of the bladder carcinoma. III. Changes of the cell cycle following thio-TEPA treatment and possible factors for kinetics of cell killing in cultured human bladder carcinoma cells (author's transl)].
    Kato T; Ishikawa K; Nemoto R
    Nihon Hinyokika Gakkai Zasshi; 1977 Nov; 68(11):1029-35. PubMed ID: 415167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.